Company: CERO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001213900-25-010230
Chunk: 405

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 405
---
 registrant relating to the offering required to be filed pursuant to Rule 424; |

| (ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |

| (iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |

| (iv) | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. II-7 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, duly authorized, in the city of South San Francisco, State of California, on the 4th day of February, 2025.

| CERO THERAPEUTICS HOLDINGS, INC. |                                                |
| By:                              | /s/ Chris Ehrlich                              |
|                                  | Chris Ehrlich                                  |
|                                  | Chairman, Chief Executive Officer and Director |
|                                  | -Principal Executive Officer                   |
| By:                              | /s/ Andrew Kucharchuk                          |
|                                  | Andrew Kucharchuk                              |
|                                  | Chief Financial Officer                        |
|                                  | -Principal Financial and Accounting Officer    |

Pursuant to the requirements of the Securities Act of 1933